Skip to content
Search

Latest Stories

A R Rahman’s performance to boost Harris’ campaign

Rahman is the first major international artist from South Asia to endorse Harris

A R Rahman’s performance to boost Harris’ campaign

LEGENDARY music composer A R Rahman has recorded a 30-minute performance video in support of vice president Kamala Harris, which is expected to provide a significant boost to her presidential campaign ahead of the November 5 general election.

Rahman, 57, is the first major international artist from South Asia to endorse Harris, who is of mixed Indian and African descent.


“With this performance, A R Rahman has added his voice to a chorus of leaders and artists who are standing up for progress and representation in America,” said Shekar Narasimhan, chairman of the AAPI Victory Fund.

“This is more than just a musical event; it’s a call to action for our communities to engage and vote for the future we want to see,” he added, following the announcement from the AAPI Victory Fund that Rahman, the globally renowned Indian composer and musician, has recorded an exclusive 30-minute performance in support of Harris's 2024 presidential campaign.

This powerful endorsement by one of the most iconic voices in the South Asian community highlights the crucial role of AAPI voters in this election and the growing momentum behind the Harris-Walz ticket, the AAPI Victory Fund said.

The exclusive performance is set to be broadcast on the AAPI Victory Fund’s YouTube channel and across major South Asian networks, including AVS and TV Asia, as part of a strategic push to galvanise support for Kamala Harris among South Asian voters worldwide.

It will be streamed on AAPI Victory Fund's YouTube on Sunday (13).

The 30-minute show will feature some of Rahman’s most beloved songs, interspersed with messages highlighting Kamala Harris's historic candidacy and her commitment to the AAPI community, according to a media release.

AAPI Victory Fund also released a teaser video on YouTube, showing A R Rahman and Indiaspora founder M R Rangaswami preparing for the performance.

(PTI)

More For You

Michael Gove expected to join House of Lords

Michael Gove leaves the Covid inquiry on March 10, 2025 in London, England. (Photo by Carl Court/Getty Images)

Michael Gove expected to join House of Lords

MICHAEL GOVE, a long-standing Conservative politician and now editor of The Spectator, is expected to be granted a peerage as part of former prime minister Rishi Sunak’s resignation honours, reports have revealed.

The 57-year-old, who stepped down as an MP last summer after nearly two decades in Parliament, will be among several former colleagues to receive the honour, reported The Financial Times.

Keep ReadingShow less
Akshay Kumar hits back at Jaya Bachchan’s ‘flop film’

Akshay Kumar at the Kesari Chapter 2 press event, addressed Jaya Bachchan’s criticism of Toilet: Ek Prem Katha and defended his socially driven films

Getty Images/ Sunday Guardian

Akshay Kumar hits back at Jaya Bachchan’s ‘flop film’ remark: ‘Only a fool would criticise such films’

At a press event for his upcoming film Kesari Chapter 2, Akshay Kumar was asked about recent remarks made by veteran actor and politician Jaya Bachchan, who criticised the title of his 2017 movie Toilet: Ek Prem Katha. Jaya Bachchan had dismissed the film during a public interaction, saying she would never watch a movie with such a title. “Is that even a name for a film?” she asked the audience, adding that the film was a “flop” based on the crowd’s lukewarm response when asked if they had seen it.

Caught off guard, Akshay Kumar initially said he wasn’t aware of the comment but responded with a measured tone: “If she’s said something, maybe she’s right. If making Toilet: Ek Prem Katha was a mistake, then I’ll accept that.”
However, he also stood by the intention behind the film. “I’ve made movies like Pad Man, Airlift, Kesari, all with a purpose. I make these films with full honesty. They try to raise awareness, and I believe that counts,” he added. He stressed that films like Toilet and Pad Man are still used by the government to educate people in villages, showing their long-term impact.

Keep ReadingShow less
Capivasertib: New NHS Pill Slows Incurable Breast Cancer Progression

Around 3,000 women each year could benefit from the treatment

iStock

New pill Capivasertib slows incurable breast cancer progression, now on NHS

A new drug for one of the most common forms of advanced breast cancer, capivasertib, is now available on the NHS in England. Around 3,000 women each year could benefit from the treatment after clinical trials showed it can slow the progression of the disease and shrink tumours in a significant number of patients.

The National Institute for Health and Care Excellence (NICE) has approved capivasertib for NHS funding. It is one of a range of treatment options offered to patients whose breast cancer has spread and is no longer curable.

Keep ReadingShow less